Clearside Biomedical, Inc. (CLSD) Financials
CLSD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 34.0 million | 49.9 million |
2023-09-30 | 34.4 million | 47.3 million |
2023-06-30 | 39.2 million | 44.2 million |
2023-03-31 | 44.7 million | 42.0 million |
CLSD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 375000 | 1.0 million |
2023-09-30 | -6.5 million | 1.1 million |
2023-06-30 | -6.4 million | 1.1 million |
2023-03-31 | -7.3 million | 1.0 million |
CLSD Net Income
No data available :(
CLSD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 28.9 million | - | 1.0 million |
2023-09-30 | 28.8 million | - | 1.1 million |
2023-06-30 | 35.0 million | - | 1.2 million |
2023-03-31 | 41.4 million | - | 1.2 million |
CLSD Shares Outstanding
CLSD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 120000 | 6.3 million | 2.9 million | - |
2023-09-30 | 445000 | 5.1 million | 2.6 million | - |
2023-06-30 | 1.1 million | 4.9 million | 3.1 million | - |
2023-03-31 | 115000 | 4.5 million | 3.2 million | - |
CLSD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 6.3 million | 20000 |
2023-09-30 | 859000 | 142000 |
2023-06-30 | 1.0 million | 213000 |
2023-03-31 | 4000 | 15000 |
CLSD
Price: $1.31
52 week price:
Earnings Per Share: -0.53 USD
P/E Ratio: -2.24
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 411200
Ebitda: -18.1 millionMarket Capitalization: 97.9 million